Shares of Axon Enterprise surged 7% to $497.34 on June 29, extending a blistering multi-day rebound that has added roughly 21% since June 22. The catalyst: a Q1 2026 earnings report that keeps paying dividends for the stock weeks after its May 6 release. Axon posted $807 million in Q1 revenue, a 34% year-over-year jump that beat the consensus estimate of $778 million by $29 million , and the company raised full-year 2026 revenue growth guidance to 30%–32%, up from 27%–30% previously . For shareholders, the question is whether the business is now growing fast enough to justify a stock that trades at roughly 185 times earnings.
AI Sales Are Exploding, and That Changes What Axon Can Charge
AI product revenue surged over 700% year-over-year , while counter-drone bookings jumped 500% and related revenue rose more than 300% . These aren't side projects — they are reshaping the revenue mix. Software and services revenue climbed 35% to $355 million , now nearly half of total sales. That shift matters because software subscriptions generate steadier, higher-margin income than one-time hardware sales.
$14.3 Billion in Future Orders Provides a Long Runway
Future contracted bookings rose 44% year-over-year to $14.3 billion , giving the company roughly four years of revenue visibility at current run rates. Annual recurring revenue — the predictable subscription income Axon earns each year — hit $1.5 billion, up 35% . That backlog insulates the business from short-term budget wobbles at police departments and federal agencies, though the biggest risk remains Axon's concentration in government budgets .
Wall Street Is Bullish, but Insiders Are Selling Into the Rally
Eighteen of 20 covering analysts carry buy ratings, with a mean 12-month target of about $662 — roughly 33% above today's price . Yet CEO Patrick Smith sold 20,000 shares for about $10 million on June 4 , and insiders have collectively sold $46 million more than they bought over the past 12 months . Insider sales don't always signal trouble, but they cap short-term enthusiasm when a stock is already richly valued.
The Valuation Asks a Lot of the Future
At a market cap of roughly $36 billion and a P/E ratio near 185x , Axon is priced for years of flawless execution. Management's own 2028 targets — $6 billion in annual revenue and a 28% profit margin (before interest, taxes, and non-cash charges) — would need to materialize in full to backfill today's price. The earnings beat is real. Whether the stock has already consumed the good news is the harder call.